Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
Dag Aarsland(King's College London), Elisabet Londos(Lund University), Katja Kossakowski(King's College London), Fredrik Boström(Lund University), Guido Alves(Stavanger University Hospital), Lennart Minthon(Lund University), Iracema Leroi(Trinity College Dublin), Francisco Pozo-Rodrı́guez(South Essex Partnership University Foundation NHS Trust), Zuzana Walker(South Essex Partnership University Foundation NHS Trust), Clive Ballard(University of Exeter)
Cited by 460
Related Papers
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science
|The Lancet Psychiatry|2020|6k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k